This week BIO Ventures for Global Health launched a new online tool called the “Global Health Primer” which aims to be a clearinghouse of information geared to the biotech industry to encourage investments in neglected disease product development. The Primer identifies gaps in the product pipeline for these diseases helping to highlight areas where companies and others can add effort and make the most progress. Content for the tool includes:
- Creation of drug target and vaccine technology profiles in addition to the neglected disease profiles. These profiles group products in development by drug target classes and vaccine technologies that may span multiple diseases.
- Expansion of each disease profile to include drug target and vaccine technology analysis that spotlights opportunities for application to neglected tropical diseases.
- Greater analysis of strengths, weaknesses, opportunities, and risks for products currently in development for neglected tropical diseases, as well as information on development tools that are available to facilitate new product development